EU Horizon Europe

Contents

EU Horizon Europe is the European Union's flagship research and innovation programme launched in 2021, succeeding Horizon 2020. It provides multi-year funding to projects across science, technology, health, climate and digital domains and links with institutions such as the European Research Council and the European Innovation Council. The programme coordinates stakeholders from universities like University of Oxford, corporations like Siemens and Nestlé, and agencies including the European Investment Bank and European Data Protection Supervisor.

Overview

Horizon Europe builds on predecessors including Framework Programme 7, Horizon 2020, and initiatives linked to the Lisbon Strategy and the Europe 2020 strategy. It interacts with agencies such as the European Commission's Directorate-General for Research and Innovation and bodies like the European Parliament and the Council of the European Union. The legal basis refers to instruments shaped in discussions with the European Council and influenced by members such as Germany, France, Italy and Spain. International cooperation engages partners like the United States Department of Energy, Japan Science and Technology Agency and the National Research Foundation (South Africa).

Strategic priorities align with policy agendas including the European Green Deal, the Digital Decade, and the Union of Innovation. The programme targets areas highlighted by the Intergovernmental Panel on Climate Change and health threats catalogued by the World Health Organization and responds to geopolitical concerns evidenced during the COVID-19 pandemic and the Russian invasion of Ukraine. Research themes intersect with projects drawn from communities such as the CERN user base, initiatives at the Max Planck Society, and collaborations with the Fraunhofer Society.

Governance involves organs of the European Commission, advisory boards including representatives from the European Research Area Committee and agencies such as the European Medicines Agency when relevant to health projects. Scientific leadership flows from the European Research Council and implementation relies on executive entities like the European Innovation Council. National contact points in member states such as Poland, Netherlands, Sweden, and Portugal support applicants, while oversight involves audit institutions like the European Court of Auditors and legal frameworks shaped by rulings from the Court of Justice of the European Union.

The multi-annual framework allocated approximately €95.5 billion, coordinated with financial bodies including the European Investment Fund and the European Central Bank's policy context. Instruments include grants managed under rules influenced by the Financial Regulation of the European Union, equity and blended finance tools interacting with the European Fund for Strategic Investments and public–private partnerships with entities like EUREKA and Clean Sky. Calls and calls for proposals reference templates used by the Marie Skłodowska-Curie Actions, the Research Executive Agency, and procurement practices seen in Horizon 2020.

Participation rules apply to legal entities from Member States of the European Union and associated countries such as Norway, Israel, and Switzerland under association agreements negotiated with the European Free Trade Association and bilateral accords informed by the European Economic Area. Academic partners include institutions like University of Cambridge, Sorbonne University, ETH Zurich, and Universidad Complutense de Madrid; industry partners include firms such as Philips, Airbus, BP, GlaxoSmithKline, and Renault. Third countries like Canada, Australia, and South Korea participate under international cooperation clauses. Eligibility criteria intersect with ethics committees exemplified by cases reviewed alongside guidelines from the European Data Protection Board.

Core components include the European Research Council grants, the Marie Skłodowska-Curie Actions, and the European Innovation Council. Missions adopt thematic orientations inspired by the European Green Deal and frameworks such as the UN Sustainable Development Goals; exemplar mission areas touch on climate adaptation referenced in reports by the Intergovernmental Panel on Climate Change, cancer research partnerships echoing initiatives like the EU-Beating Cancer Plan, and urban transformation initiatives seen in the Urban Agenda for the EU. Sectoral programmes intersect with consortia including the Clean Hydrogen Partnership, the Fuel Cells and Hydrogen Joint Undertaking, and aerospace collaborations linked to Galileo and Copernicus.

Impact assessments cite beneficiary institutions such as the European Molecular Biology Laboratory and technological outcomes linking to start-ups accelerated by organizations like EIT Digital and incubators modeled on Station F. Evaluations involve metrics familiar to bodies like the European Court of Auditors and research assessment panels used by the ERC Scientific Council. Criticism has been leveled over administrative complexity noted by universities including Heidelberg University and firms such as Vattenfall, debates on intellectual property involving stakeholders like Novartis and Bayer, and political disputes among states including Poland and Hungary over conditionality tied to rule-of-law mechanisms debated in the European Council and adjudicated by the Court of Justice of the European Union.

Category:European Union research programs